5 protocol(s) meet the specified criteria
Disease Site: Other Hematopoietic
Protocol No.TitleStatus
COG-AALL0331Standard Risk B-precursor Acute Lymphoblastic LeukemiaOpen
GVHD1202Predictive Biomarkers For Pediatric Chronic Graft-­‐Versus-­‐Host DiseaseOpen
LCCC1241Complementary and Alternative medicine use at UNC clinicsOpen
NEOD001-CL002A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care vs. Placebo Plus Standard of Care in Subjects with Light Chain (AL) AmyloidosisOpen
SGN33A-004A Phase 1/2 Study of Vadastuximab Talirine (SGN-CD33A) in Combination with Azacitidine in Patients with Previously Untreated International Prognostic Scoring System (IPSS) Intermediate-2 or High Risk Myelodysplastic Syndrome (MDS)Open